Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedThe Record History page now lists Revision: v3.5.4, replacing the previous v3.5.3. This indicates a small site release updating the page's version label.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe record history now shows a new latest revision, v3.5.3, replacing the previous v3.5.2. This marks a minor platform update to the page's revision metadata.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedAdded an entry for Revision: v3.5.2 and removed Revision: v3.5.0 in the page's revision history. This reflects an incremental update to the historical record, without altering the main content presented to users.SummaryDifference0.1%

- Check56 days agoChange DetectedTerminated status was added to the study record history, and new sections Oversight, Study Status, and Study Identification were introduced. The previous Active, not recruiting status and related status details were removed.SummaryDifference1%

- Check63 days agoChange DetectedA new revision v3.5.0 was added to the Record History, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check70 days agoChange DetectedDifference0.1%

Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.